![Nathalie Cartier-Lacave](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Nathalie Cartier-Lacave
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BrainVectis SAS
![]() BrainVectis SAS BiotechnologyHealth Technology BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France. | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 | - |
Oprichter | 01-01-2015 | - |
Loopbaan van Nathalie Cartier-Lacave
Statistieken
Internationaal
Frankrijk | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
BrainVectis SAS
![]() BrainVectis SAS BiotechnologyHealth Technology BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France. | Health Technology |